Paperpal Prime Logo

Clinical and Translational Allergy : Impact Factor & More

eISSN: 2045-7022pISSN: 2045-7022
JournalOpen Access

Key Metrics

CiteScore
6.8
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q2Immunology
SNIP
1.57
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Clinical and Translational Allergy

Clinical and Translational Allergy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Article-by-article
Article Processing ChargesUSD 2760 | EUR 2500 | GBP 2200
Publication Time11
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorEuropean Academy for Allergy and Clinical Immunology
FrequencyArticle-by-article
Publication Start Year2011
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 11
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Clinical and Translational Allergy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Clinical and Translational Allergy

Treatment Choice and Cardiovascular Risk in Chronic Spontaneous Urticaria.
  • 1 Oct 2026
  • Clinical and translational allergy
Real-World Effectiveness and Safety of Triple-Mite SCIT With Dermatophagoides and Blomia tropicalis.
  • 1 Oct 2026
  • Clinical and translational allergy
Association of Mitochondrial DNA Copy Number With Atopic Dermatitis in Children
  • 1 Oct 2026
  • Clinical and Translational Allergy
Is It Safe to Reduce Inhaled Corticosteroid Dose in Severe Asthma Patients Receiving Biologic Therapy?
  • 1 Oct 2026
  • Clinical and translational allergy
Short\u2010Course Subcutaneous Immunotherapy With Mannan\u2010Conjugated Birch Pollen Allergoids: Consistent Clinical and Immunological Improvements
  • 1 Oct 2026
  • Clinical and Translational Allergy
NSAID Tolerance Can Be Restored in NECD Even in the Absence of Complete Remission of Urticaria.
  • 1 Oct 2026
  • Clinical and translational allergy
Treatment Choice and Cardiovascular Risk in Chronic Spontaneous Urticaria.
  • 1 Oct 2026
  • Clinical and translational allergy
Real-World Effectiveness and Safety of Triple-Mite SCIT With Dermatophagoides and Blomia tropicalis.
  • 1 Oct 2026
  • Clinical and translational allergy
Association of Mitochondrial DNA Copy Number With Atopic Dermatitis in Children
  • 1 Oct 2026
  • Clinical and Translational Allergy
Is It Safe to Reduce Inhaled Corticosteroid Dose in Severe Asthma Patients Receiving Biologic Therapy?
  • 1 Oct 2026
  • Clinical and translational allergy
Short\u2010Course Subcutaneous Immunotherapy With Mannan\u2010Conjugated Birch Pollen Allergoids: Consistent Clinical and Immunological Improvements
  • 1 Oct 2026
  • Clinical and Translational Allergy
NSAID Tolerance Can Be Restored in NECD Even in the Absence of Complete Remission of Urticaria.
  • 1 Oct 2026
  • Clinical and translational allergy

FAQs on Clinical and Translational Allergy